The important investigations of Carson, Dern and Beutler and their co-workers (1-8) have identified an inherent deficiency of erythrocyte glucose-6-phosphate dehydrogenase as the biochemical basis for the hemolytic anemia induced in "sensitive" individuals by administration of primaquine and certain related compounds. The relationship between this enzyme deficiency and the mechanism of the hemolytic response remains to be defined. The hemolysis certainly involves disruptive changes in the red cell membrane. The possibility of a direct action of primaquine on the membrane must be seriously considered. As Rothstein (9) has pointed out, it is important to examine the effects of toxic agents on the membranes of the cells as well as their effects on intracellular metabolism, since any administered agent will, of course, first contact the cell membrane.
(Submitted for publication July 25, 1960 ; accepted August 19, 1960) The important investigations of Carson, Dern and Beutler and their co-workers (1) (2) (3) (4) (5) (6) (7) (8) have identified an inherent deficiency of erythrocyte glucose-6-phosphate dehydrogenase as the biochemical basis for the hemolytic anemia induced in "sensitive" individuals by administration of primaquine and certain related compounds. The relationship between this enzyme deficiency and the mechanism of the hemolytic response remains to be defined. The hemolysis certainly involves disruptive changes in the red cell membrane. The possibility of a direct action of primaquine on the membrane must be seriously considered. As Rothstein (9) has pointed out, it is important to examine the effects of toxic agents on the membranes of the cells as well as their effects on intracellular metabolism, since any administered agent will, of course, first contact the cell membrane.
In normal red blood cells, the studies of Beutler, Dern and Alving (5) indicate that hemolysis is produced in vitro only by concentrations of primaquine greatly in excess of pharmacologic blood levels. A prehemolytic loss of K+ is, however, induced by subhemolytic concentrations of these agents. It was the purpose of the present investigations to study these in vitro prelytic abnormalities in red cell permeability. It is accepted that the event of hemolysis occurring within a population of red cells represents an "all or none" response of individual cells, although the degree of hemolglobin loss by the individual cell varies with the lytic stimulus (10) .
In the case of prelytic phenomena involving changes in erythrocyte permeability, manifested by loss of K+, red blood cells may respond in a heterogeneous fashion, as discussed by Ponder and Cox (11, 12) . Such a heterogeneous response suggests the possibility of an all or none response on the part of some of the red cells as an explanation for a portion of the prelytic loss of K+. Very significant contributions to the problem of individual red cell behavior were made by Passow and Tillman (13) in their studies of the prelytic loss of K+ from human red blood cells exposed to Pb++ and by Eckel (14, 15) who has studied the exchangeable K+ compartments of red cells treated with sodium fluoride. The latter investigator demonstrated a rapidly exchangeable K+ compartment as well as a more slowly exchangeable K+ compartment within the red cell sample and suggested that the rapidly exchangeable compartment represented complete K+ permeability in some of the cells. Passow, Rothstein and Loewenstein (16) , working with yeast cells, have also demonstrated that the loss of K+ following exposure to a variety of basic redox dyes occurs as an all or none event for individual cells.
In the present investigation, the prelytic loss of K+ and gain of Na+ induced by primaquine, methylene blue, and acetylphenylhydrazine was studied by analyzing dose-response and time-response relationships as well as osmotic fragility changes at varying times and drug concentrations.
METHODS
The blood samples from hematologically normal adult male and female donors were defibrinated with glass beads. The blood was centrifuged at 1,750 X G for 10 minutes and the buffy coat removed by aspiration. The red cells were resuspended in their own serum. This suspension will hereafter be referred to as whole blood.
The whole blood was incubated in Warburg vessels 130 with varying concentrations of primaquine diphosphate,l methylene blue, or acetylphenylhydrazine. Concentrations of each agent, 10 times the final desired concentration, were prepared in isotonic sodium chloride solution, adjusted to pH 7.4 or 7.8 with dilute NaOH and added to 9 vol of the whole blood. The hematocrits of the experimental preparations were adjusted to between 35 and 40 per cent. Concentrations of primaquine are expressed in moles per liter of whole blood, since the primaquine was rapidly distributed into both the red cell fraction and the serum.
Serum samples were removed at varying time intervals and the loss of K+ was calculated as outlined by Ponder (17) and expressed as a percentage of the total K+ content of the cells. K+ and Na' determinations were made with a Beckman flame photometer. W\ith the exception of a few experiments in which hemolysis ranged from 1 to 8 per cent, the great majority of the observations were made on samples in which no hemolysis had occurred.
Osmotic fragility determinations were performed according to the method of Parpart and colleagues (18) . \Vith severely damaged cells, some hemolysis occurred in 0.9 per cent NaCl, although there had been none in the whole blood. An additional tube containing 1.0 per cent NaCl was included in the fragility test to mimic the additional osmotic effect of the serum protein, and no additional hemiolysis above that found in the serum itself was observed at this concentration of NaCl. Since estimation of per cent hemolysis on the basis of plasma hemoglobin measurements may introduce an error related to the amount of hemoglobin retained by individual hemolyzed or ghost cells, a more specific visual estimate of the percentage of hemolyzed cells was carried out in a manner somewhat similar to the original osmotic fragility studies of Whitby and Hynes (19) , who used red blood cell counts. Stained cell preparations were made by placing 50 1l of the experimental cell suspensions into 10 ml of the 0.70 per cent NaCl-PO buffer (pH 7.4) described by and allowing the injured cells to hemolyze during 20 minutes of incubation at room temperature. The lytic stimulus of 0.70 per cent NaCI was sufficient to lyse those cells which had a marked alteration in permeability, yet did not fragment the lysed cells beyond recognition, as did more dilute NaCl solutions. The cell suspension then was centrifuged, the supernatant aspirated and 1 ml of Dacie's solution (20) changes in fragility could 1)e correlated with alterations in red cell permeability, as manifested by loss of K+. Figure 3 is a diagram of osmotic fragility tests obtained after exposing aliquots of a whole blood sample to 8 x 10-4 M primaquine for 180 minutes or to 2 x 10-3 MI primaquine for 40, 80 and 180 minutes. Figure 3 also includes an osmotic fragility curve obtained after incubation for 180 minutes of a control aliquot from the same blood sample in the absence of primaquine. In neither of these concentrations of drug was any hemolysis produced in the whole blood. The osmotic fragility patterns produced by these two concentrations of drug clearly illustrate two types of induced changes in the erythrocytes. At the lower drug concentration, 8 X 10-4 MI, increased fragility of the whole cell population is evident and the entire curve is shifted symmetrically to the left. At the higher drug concentration, however, in addition to the symmetrical shift of the upper portion of the curve there is an evident upward shift of the curve from the baseline, increasing with time. This change in osm-notic fragility is indicative of a profound change in the membrane of some of the cells, which makes them readily susceptible to osmotic lysis. Figure 4 illustrates two of these stained red cell ghost preparations; Figure 4A was prepared from a control sample of blood without primnaquine which was incubated and treated in the same fashion as was a primaquine-treated sample with 50 per cent ghosts, shown in 4B. Figure 5 represents (27) , it can be shown that 99.99 per cent of normal erythrocytes examined by them had a volume less than 1.24 times the mean volume (3 SD from the mean). Turning to the data presented in Figure 5 , however, it is apparent that if there were no loss of K+ Figure 5 represented a loss greater than that accounted for by individual cell breakdown. mal erythrocytes and red cells incubated with varying concentrations of primaquine was compared. Normal red cells produced 17.0 ± 6.0 (SD) mg lactic acid per 100 ml RBC per 2 hours, while red cells incubated with 1 x 10-3 AI primaquine produced 14.9 ± 1.1 (SD) mg per 100 ml and cells exposed to 3 x 10-3 M primaquine produced 17.7 + 5.3 (SD) mg per 100 ml during the same period. There are no significant differences among these results.
The reduced glutathione content of red blood cells from six normal individuals remained at normal levels after the cells were incubated with concentrations of primaquine that caused large losses of K+. The mean pre-incubation value for reduced glutathione was 62.9 ± 19.7 mg per 100 ml of normal red blood cells. Aliquots of the same red cell samples after 2 hours' incubation at 370 C in the absence of primaquine were found to contain 70.6 ± 16 mg per 100 ml of reduced glutathione. After 2 hours' incubation with 1 x 10-3 WI primaquine, a value of 72.7 ± 13.0 mg per 100 ml of reduced glutathione was obtained, and after incubation with 3 x 10-3 M primaquine, 61.7 ± 10.7 mg per 100 ml of reduced glutathione was present.
Methemioglolin formation was measured in red cell samples after 2 hours of incubation and found to equal 2 per cent of the total hemoglobin present in untreated samples. The same value was found for red cell samples treated with 2, 5 or 10 X 10-4 MV concentrations of primaquine, concentrations which result in significant loss of K+. Treatment with a concentration of 2 x 10-3 MI primaquine, which induces a 50 per cent loss of K+, resulted in an increase in amounts of methemoglobin to 8 to 12 per cent of the total hemoglobin after 2 hours of incubation.
pH. The loss of K+ induced by treatment of erythrocytes with 3 x 10-3 M primaquine was greater at pH 7.8 than at pH 7.4; 51. Other agents. The effects of other agents, including methylene blue and acetylphenylhydrazine, on the loss of erythrocyte K+ was evaluated. These agents were studied in systems at a pH of 7.8. Methylene blue induced 0 to 100 per cent loss of K+ over a concentration range extending from 4 X 10-4 M to 6 X 10-3 MI, when the red cells were suspended in serum. Acetylphenylhydrazine in serum produced a similar effect at concentrations between 3 x 10-4 and 2.4 x 10-2 M. Both of these agents, when studied in zitro like primaquine, demonstrated a dual relationship between loss of K+ and osmotic fragility, and both also exerted their effects on loss of K+ more readily in serum than in NaCl solution.
DISCUSSION
Based on the time-response and osmotic fragility data presented, the in vitro prelytic loss of K+ induced by primaquine, methylene blue and acetylphenylhydrazine is composed of two (13) and Eckel (14, 15) , which these authors interpreted as evidence of an "all or none" response by segments of a red cell population. In addition, the finding in the present investigation of a symmetrical shift of the entire osmotic fragility curve with time also correlates well with the observations of these other investigators; the symmetrical shift in osmotic fragility can be interpreted similarly to represent some increased permeability of all of the remaining cells. One of the most interesting, although tinexplained, observations is the enhancing effect of serum on the loss of K+ induced by all three agents studied. The enhancing effect of serum on anilineinduced hemolysis has been known since it was first described by Browning and Mackie in 1914 (38) and again in 1933 by Ponder (39, 40 5. Methylene blue and acetylphenylhydrazine induce a similar prelytic loss of K+, and like primaquine, these agents exert a greater effect in the presence of serum.
